Dr. Jennifer E. Miller

Dr. Jennifer E. Miller

Assistant Professor, NYU School of Medicine

Jennifer E. Miller, PhD, is an Assistant Professor in NYU School of Medicine and President of the nonprofit, Bioethics International. She is also the Creator of the Good Pharma Scorecard, an index that ranks all new drugs and large pharmaceutical companies on their ethics and public health performance to help recognize good practices in companies, improve trustworthiness, and incentivize change where needed.  Prior to joining NYU, Dr. Miller was based at Harvard University’s Edmond J. Safra Center for Ethics and Duke University’s Kenan Institute for Ethics and Fuqua School of Business.

Committed to public service, Dr. Miller currently serves on NYU’s Pharmacy and Therapeutics Committee and Stem Cell Research Oversight IRB as well as the J&J-NYU Compassionate-Use Advisory Committee (monitor). Previously, she served on the Center for Disease Control and Prevention’s (CDC) Task Force for Pediatric Emergency Mass Critical Care, the American Medical Association’s (AMA) Advanced Disaster Life Support Education Consortium, as a consultant to the United Nations Economic and Social Council, and on the PCORI-NIH Collaboratory.

A prolific writer, Dr. Miller has authored over 35 publications, including for Nature MedicineHealth Affairs, the Hastings Center Report, The Scientist, the Journal of Law, Medicine, and EthicsThe American Journal of Bioethics, Cambridge Quarterly of Healthcare Ethics, Pediatric Critical Care Medicine, The Journal of Pre-hospital and Disaster Medicine, and the Journal of the Society for Clinical Trials. She was a Fox News pundit from 2009 to 2012 and remains a commentator for print, radio and television news media, frequently featured on CBS news, Wall Street Journal, Washington Post, Bloomberg News, Forbes, and NPR.

Dr. Miller’s current work explores the ethics, transparency and governance of how medicines, biologics, and health technologies are researched, developed, marketed, priced, and made accessible to patients globally. She also specializes in the ethics of data sharing, focusing on the medical and biotechnology sectors.